The CEO of Turing Pharmaceuticals is defending his decision to raise the price of the life-saving drug Daraprim from $13.50 to $750 a tablet. Outrage over his decision has spread to the campaign trial and triggered instability on Wall Street. New York Times Reporter Andrew Pollack and Infectious Disease Specialist, Dr. Frank Esper join NewsNation.Sept. 22, 2015
UP NEXT
Active shooter reported near Morgan State University
00:22
Watch McCarthy's full remarks after being ousted as speaker
47:48
House votes to oust Speaker McCarthy
01:40
Gaetz: 'Chaos is Speaker McCarthy'
01:26
Garth Brooks, Trisha Yearwood team up with Habitat for Humanity for affordable housing
09:08
Steve Inskeep: Lincoln found common ground with those who differed from him